Results 41 to 50 of about 2,041,012 (194)

Treatment of unresectable intrahepatic cholangiocarcinoma with yttrium-90 radioembolization: a systematic review and pooled analysis. [PDF]

open access: yes, 2015
Radioembolization with yttrium-90 microspheres offers an alternative treatment option for patients with unresectable intrahepatic cholangiocarcinoma (ICC).
Gill, R.S.   +5 more
core   +2 more sources

Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors

open access: yesWorld Journal of Surgical Oncology, 2011
Background The aim of this study was to evaluate the success of selective intraarterial radionuclide therapy (SIRT) with Yttrium-90 (Y-90) microspheres in liver metastases of different tumors.
Ozkan Elgin   +4 more
doaj   +3 more sources

Application and research progress of90Y microspheres internal radiation therapy in colorectal cancer with liver metastasis

open access: yesZhongguo aizheng zazhi, 2021
Colorectal cancer (CRC) is the second leading cause of cancer death worldwide. Hepatic metastases, which account for the major cause of mortality in CRC patients, occur in about half of the patients when the primary tumor is discovered or after the ...
张迎强, 林岩松
doaj  

177Lu‐labeled amidoxime‐functionalized biodegradable microspheres for transarterial radioembolization of hepatocellular carcinoma

open access: yesPrecision Radiation Oncology, EarlyView.
Scheme 1. Schematic illustration of the synthesis and therapeutic evaluation of PLA‐g‐PAO microspheres (PLA‐g‐PAO‐Ms). Monodisperse PLA microspheres (PLA‐Ms) were initially fabricated via microfluidic technology. Surface grafting of acrylonitrile monomers was subsequently achieved through radiation‐induced graft polymerization, followed by ...
Xingliang Liu   +7 more
wiley   +1 more source

Application and research progress of selective internal radiation therapy with90Y microspheres in hepatocellular carcinoma

open access: yesZhongguo aizheng zazhi, 2021
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related deaths in China. About 85% of HCC patients are at intermediate or advanced stage upon diagnosis, of which the common treatment strategy is the combination of systemic ...
牛 娜, 林岩松
doaj  

Radioembolization with Yttrium-90 resin microspheres in treatment of HCC with or without PVT: Initial Egyptian experience [PDF]

open access: yes, 2013
Background/AimHepatocellular carcinoma (HCC) is the most common primary malignancy of the liver. Radioembolization with yttrium-90 (Y-90) microspheres is a new concept in radiation therapy for HCC.
El Ghazaly, Hesham A.   +3 more
core   +1 more source

Interventional oncology in children: Where are we now?

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
Abstract Paediatric Interventional Oncology (IO) lags behind adult IO due to a scarcity of specific outcome data. The suboptimal way to evolve this field is relying heavily on adult experiences. The distinct tumour types prevalent in children, such as extracranial germ cell tumours, sarcomas, and neuroblastoma, differ strongly from those found in ...
Premal Amrishkumar Patel   +1 more
wiley   +1 more source

Plastic deformation of dense nanocrystalline yttrium oxide at elevated temperatures [PDF]

open access: yes, 2012
Nanocrystalline yttrium oxide, Y2O3 with 110 nm average grain size was plastically deformed between 800 ◦C and 1100 ◦C by compression at different strain rates and by creep at different stresses. The onset temperature for plasticity was at 1000 ◦C. Yield
Estournès, Claude   +4 more
core   +1 more source

Emerging locally delivered antimicrobial and immunomodulatory approaches for the prevention/treatment of peri‐implant diseases

open access: yesPeriodontology 2000, EarlyView.
Abstract Peri‐implant diseases are dysbiosis‐mediated inflammatory disorders that occur in susceptible hosts. Antimicrobials and immunomodulatory agents therefore might be pertinent as adjunctive measures in the treatment of such disorders. The aim of this narrative review was to examine the existing evidence and assess the effectiveness of emerging ...
Alberto Monje   +3 more
wiley   +1 more source

Discordance between 90Y-PET/CT(MR)-estimated activity and dose calibrator measured administered activity: an international study in SIRT patients treated with resin and glass microspheres

open access: yesEJNMMI Physics
Purpose Therapeutic administration of 90Y-loaded microspheres is routinely used for primary and secondary liver tumours. For activity-based therapeutic prescription the activity must be within 10% of the intended activity.
Thomas Carlier   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy